Cover Image
市場調查報告書

印度的醫藥品製造業界:2015∼2020年

Pharmaceuticals Manufacturing Industry in India 2015-2020

出版商 NOVONOUS 商品編碼 338545
出版日期 內容資訊 英文 174 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印度的醫藥品製造業界:2015∼2020年 Pharmaceuticals Manufacturing Industry in India 2015-2020
出版日期: 2015年08月24日 內容資訊: 英文 174 Pages
簡介

印度的醫藥品製造市場,預計到2020年以年複合成長率19.76%擴大。在發展中國家的成長鈍化之下,由於今後數年主要藥物的專利失效,對學名藥廠商來說預計將相當順利。

本報告提供印度的醫藥品製造業界相關的詳細調查、至2020年的成長預測、市場上競爭趨勢、企業簡介、SWOT分析、未來趨勢與機會、策略性建議等彙整資料。

第1章 摘要整理

第2章 簡介

第3章 印度的醫藥品產業的需求

  • 印度的人口
  • 景氣變動
  • 藥物安全性

第4章 印度的醫藥品產業相關市場區隔與預測

  • 印度的醫藥品製造業界的未來:2015∼2020年

第5章 印度的醫藥品市場上EXIM方案

  • 醫藥品出口方案
  • 醫藥品進口方案

第6章 印度的醫藥品製造業界的成長促進因素與阻礙因素

第7章 印度的醫藥品產業相關政策

第8章 印度的醫藥品產業相關風險

  • 信用風險
  • 政策風險
  • 技術性風險

第9章 印度的醫藥品產業相關產業團體

第10章 印度的醫藥品產業相關政府機關

第11章 印度的醫藥品製造業界的主要企業簡介

  • Abbott India Limited
  • Biocon Limited
  • CIPLA Limited
  • Dr. Reddy's Laboratories
  • Sun Pharmaceuticals Limited
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Torrent Pharmaceuticals Limited
  • Divis Laboratories Limited
  • IPCA Laboratories Limited

第12章 印度的醫藥品產業的競爭環境

第13章 印度的醫藥品製造業界分析模式

第14章 印度的醫藥品產業的現狀及未來趨勢

第15章 策略性建議

  • 對終端用戶
  • 對醫藥品廠商
  • 對政策決策者

圖表

目錄
Product Code: NOV0815002

Indian pharmaceuticals manufacturing market is expected to grow at a CAGR of 19.76% by 2020. This is despite slowing growth in developed markets; players in generics are expected to perform reasonably well due to significant numbers of exclusivity losses and patent expirations on leading drugs in the upcoming years.

“Pharmaceuticals Manufacturing Industry in India is expected to be worth US$ 41.92 billion by 2020.”

The Indian Pharmaceutical Industry is in middle of big changes and not only the Industry is expected to accommodate Demographic, Epidemiological, and economic shifts in the world, but also has to upgrade manufacturing practices and match rigid standards from time to time in order to produce world-class medicines. Also, the pharmaceutical manufacturers are expected to embrace newer methods and effective practices - right from the ways drugs are discovered, then on manufacturing and packaging fronts, and to the ways drugs are made available to consumers.

The generics portfolio dominates the Indian Pharma Industry which accounts for over 70% of the market. The Indian Pharma market is largely fragmented. With a string of Mergers and Acquisitions within the market in the last decade, consolidation of the overall market has been the key Industry feature.

India's Pharmaceutical sector accounts for nearly 1.4% of the global pharmaceutical industry in terms of value 10% in terms of volume.

Spanning over 176 pages and 174 exhibits, “Pharmaceuticals Manufacturing Industry in India 2015-2020” report presents an in-depth assessment of the pharmaceuticals manufacturing industry from 2015 till 2020.

The report has detailed company profiles including their position in pharmaceuticals manufacturing industry value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for ten key players in Indian market namely Abbott India, Biocon Limited, CIPLA Limited, Dr. Reddy's Laboratories, Sun Pharmaceuticals Limited, Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Limited, Divis Laboratories Limited and IPCA Laboratories Limited.

Scope of the Report:

  • This report provides a detailed view of Indian pharmaceuticals manufacturing market.
  • This report identifies the need for focusing on pharmaceuticals sector in India.
  • This report provides detailed information on growth forecasts for pharmaceuticals manufacturing industry in India up to 2020.
  • The report identifies the growth drivers and inhibitors for pharmaceuticals manufacturing industry in India.
  • This study also identifies policies related to pharmaceuticals market in India.
  • The report identifies various credit, policy and technical risks associated with pharmaceuticals manufacturing industry in India.
  • The report identifies EXIM scenario for pharmaceuticals products market in India.
  • The report identifies top countries exporting pharmaceuticals products to India.
  • The report identifies top countries importing pharmaceuticals products from India.
  • This report has detailed profiles 10 key players in Indian pharmaceuticals manufacturing market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis.
  • This report covers in details the competitive landscape in Indian pharmaceuticals manufacturing market.
  • This report identifies key industry bodies and associations and their role in Indian pharmaceuticals manufacturing market.
  • This report identifies key government bodies and their role in Indian pharmaceuticals market.
  • This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian pharmaceuticals manufacturing market.
  • This report provides Porter's Five Forces analysis for pharmaceuticals manufacturing industry in India.
  • This report provides SWOT (strengths, weakness, opportunities and threats) analysis for pharmaceuticals manufacturing industry in India.
  • This report provides future trends and opportunities for pharmaceuticals manufacturing market in India.
  • This report also provides strategic recommendations for policy makers, pharmaceuticals manufacturers and end users.

Companies covered:

  • 1. Abbott India
  • 2. Biocon Limited
  • 3. CIPLA Limited
  • 4. Dr. Reddy's Laboratories
  • 5. Sun Pharmaceuticals Limited
  • 6. Lupin Limited
  • 7. Aurobindo Pharma Limited
  • 8. Torrent Pharmaceuticals Limited
  • 9. Divis Laboratories Limited
  • 10. IPCA Laboratories Limited

Table of Contents

1. Executive Summary

  • Scope of the Pharmaceutical Manufacturing Industry in India 2015 - 2020 Report
  • Research Methodology

2. Introduction - Pharma Industry in India

  • 2.1. Pharma Manufacturing Industry in India
    • 2.1.1. Pharma Manufacturing Industry Value Chain

3. Need for Pharmaceuticals Industry in India

  • 3.1. Large Population of India
  • 3.2. Economic viability
  • 3.3. Drug Security

4. Market Segments & Forecast for Pharmaceuticals Industry in India

  • 4.1. Forecasts for Indian Pharma Manufacturing Industry 2015-2020

5. EXIM Scenario in Indian Pharmaceuticals Market

  • 5.1. Export Scenario of Indian Pharmaceutical Products Market
    • 5.1.1. Value of Pharmaceutical Products Exports from India 2003-04 to 2013-14 in US$ million
    • 5.1.2. Volume of Pharmaceutical Products Exports from India 2003-04 to 2013-14 in Thousands Kg
    • 5.1.3. Top 5 Nations Importing Indian Pharmaceutical Products
  • 5.2. Import Scenario of Indian Pharmaceutical Products Market
    • 5.2.1. Value of Pharmaceutical Products Imports in India 2003-04 to 2013-14 in US$ million
    • 5.2.2. Volume of Pharmaceutical Products Imports in India 2003-04 to 2013-14 in Thousands Kg
    • 5.2.3. Top 5 Nations Exporting Pharmaceutical Products to India

6. Growth Drivers and Inhibitors for Pharmaceuticals Manufacturing Industry in India

  • 6.1. Growth Drivers for Pharmaceuticals Manufacturing Industry in India
  • 6.2. Growth Inhibitors for Pharmaceuticals Manufacturing Industry in India

7. Policies Related to Pharmaceuticals Industry in India.

  • 7.1. Central Government Policies
    • 7.1.1. Essential Commodities Act 1955
    • 7.1.2. Drugs and Cosmetics Act 1940(As amended in June 2005)
    • 7.1.3. National Pharmaceutical Pricing Policy 2012
    • 7.1.4. Drug Price Control Orders (DPCO)
    • 7.1.5. Drug Policy 1986
    • 7.1.6. Pharmaceutical Policy - 2002
  • 7.2. Guidelines related to Clinical Trial in India
  • 7.3. Guidelines related to Marketing in Indian Pharmaceuticals Industry

8. Risks Associated with Pharmaceutical Industry in India

  • 8.1. Credit Risk
    • 8.1.1. Credit Risks Associated with Indian Pharmaceuticals Manufacturing Industry
  • 8.2. Policy Risk
    • 8.2.1. Policy Risks Associated with Indian Pharmaceuticals Manufacturing Industry
  • 8.3. Technical Risk
    • 8.3.1. Technical Risks Associated with Indian Pharmaceuticals Manufacturing Industry

9. Industry Associations Related to Indian Pharmaceuticals Industry

  • 9.1. Indian Drug Manufacturers' Association (IDMA)
  • 9.2. Indian Pharma Machinery Manufacturers Association (IPMMA)
  • 9.3. Indian Pharmaceutical Association (IPA)
  • 9.4. Organisation of Pharmaceutical Producers of India (OPPI)

10. Government Bodies Related to Indian Pharmaceuticals Industry

  • 10.1. Department of Pharmaceuticals
  • 10.2. Ministry of Chemicals & Fertilizers
    • The Department of Fertilizers (DOF)
  • 10.3. National Pharmaceutical Pricing Authority (NPPA)

11. Profile of Key Players in India Pharmaceuticals Manufacturing Industry

  • 11.1. Abbott India Limited
    • 11.1.1. Company Profile
    • 11.1.2. Abbott India in Pharma Manufacturing Value Chain
    • 11.1.3. Abbott India: Financial Performance
    • 11.1.4. Abbott India: Business Strategy
      • 11.1.4.1. Product Level Strategy
    • 11.1.5. SWOT Analysis of Abbott India
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.1.6. Key Customers of Abbott India
  • 11.2. Biocon Limited
    • 11.2.1. Company Profile
    • 11.2.2. Biocon Limited in Pharmaceutical Manufacturing Value Chain
    • 11.2.3. Biocon Limited: Financial Performance
    • 11.2.4. Biocon Limited: Business Strategy
      • 11.2.4.1. Product Level Business Strategy
      • 11.2.4.2. Service Level Business Strategy
    • 11.2.5. SWOT Analysis of Biocon Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.2.6. Key Customers of Biocon Limited
  • 11.3. CIPLA Limited
    • 11.3.1. Company Profile
    • 11.3.2. CIPLA Limited in Pharmaceutical Manufacturing Value Chain
    • 11.3.3. CIPLA Limited: Financial Performance
    • 11.3.4. CIPLA Limited: Business Strategy
      • 11.3.4.1. Product Level Business Strategy
      • 11.3.4.2. Service Level Business Strategy
    • 11.3.5. SWOT Analysis of CIPLA Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.3.6. Key Customers of CIPLA Limited
  • 11.4. Dr. Reddy's Laboratories
    • 11.4.1. Company Profile
    • 11.4.2. Dr. Reddy's Laboratories in Pharma Manufacturing Value Chain
    • 11.4.3. Dr. Reddy's Laboratories: Financial Performance
    • 11.4.4. Dr. Reddy's Laboratories: Business Strategy
      • 11.4.4.1. Product Level Business Strategy
      • 11.4.4.2. Service Level Business Strategy
    • 11.4.5. SWOT Analysis of Dr. Reddy's Laboratories
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.5. Sun Pharmaceuticals Limited
    • 11.5.1. Company Profile
    • 11.5.2. Sun Pharmaceuticals Limited in Pharma Manufacturing Value Chain
    • 11.5.3. Sun Pharmaceuticals Limited: Financial Performance
    • 11.5.4. Sun Pharmaceuticals Limited: Business Strategy
    • 11.5.5. SWOT Analysis of Sun Pharmaceuticals Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.5.6. Key customers of Sun Pharmaceuticals Limited
  • 11.6. Lupin Limited
    • 11.6.1. Company Profile
    • 11.6.2. Lupin Limited in Pharma Manufacturing Value Chain
    • 11.6.3. Lupin Limited: Financial Performance
    • 11.6.4. Lupin Limited: Business Strategy
      • 11.6.4.1. Product Level Strategy
    • 11.6.5. SWOT Analysis of Lupin Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.7. Aurobindo Pharma Limited
    • 11.7.1. Company Profile
    • 11.7.2. Aurobindo Pharmaceuticals in Pharma Manufacturing Value Chain
    • 11.7.3. Aurobindo Pharmaceuticals: Financial Performance
    • 11.7.4. Aurobindo Pharmaceuticals: Business Strategy
    • 11.7.5. SWOT Analysis of Aurobindo Pharmaceuticals
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.8. Torrent Pharmaceuticals Limited
    • 11.8.1. Company Profile
    • 11.8.2. Torrent Pharmaceuticals in Pharma Manufacturing Value Chain
    • 11.8.3. Torrent Pharmaceuticals: Financial Performance
    • 11.8.4. Torrent Pharmaceuticals: Business Strategy
    • 11.8.5. SWOT Analysis of Torrent PharmaceuticalsLimitied
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.8.6. Key Customers of Torrent Pharmaceuticals
  • 11.9. Divis Laboratories Limited
    • 11.9.1. Company Profile
    • 11.9.2. Divis Laboratories Limited in Pharma Manufacturing Value Chain
    • 11.9.3. Divis Laboratories: Financial Performance
    • 11.9.4. Divis Laboratories: Business Strategy
    • 11.9.5. SWOT Analysis of Divis Laboratories Limtied
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 11.10. IPCA Laboratories Limited
    • 11.10.1. Company Profile
    • 11.10.2. IPCA Laboratories Limited in Pharmaceutical Manufacturing Value Chain
    • 11.10.3. IPCA Laboratories Limited: Financial Performance
    • 11.10.4. IPCA Laboratories Limited: Business Strategy
    • 11.10.5. SWOT Analysis of IPCA Laboratories Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
    • 11.1.10.6. Key Customers of IPCA Laboratories Limited

12. Competitive Landscape in Pharmaceuticals Industry in India

13. Analysis Models for Indian Pharmaceuticals Manufacturing Industry

  • 13.1. PESTEL Analysis of Pharmaceuticals Manufacturing Industry in India
  • 13.2. SWOT Analysis of Indian Pharmaceuticals Manufacturing Industry
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 13.3. Porter's Five Forces Analysis of Indian Pharmaceuticals Manufacturing Industry

14. Current & Future Trends in Pharmaceuticals Industry in India

15. Strategic Recommendations

  • 15.1. Recommendations for End Users
  • 15.2. Recommendations for Pharmaceuticals Manufacturers
  • 15.3. Recommendations for Policy Makers
  • List of Exhibits
  • Notes
  • Company Information

List of Exhibits

  • Exhibit 2.1: Healthcare spending as % of GDP in populous countries - 2012
  • Exhibit 2.2: Pharma Manufacturing Industry Value Chain
  • Exhibit 3.1: Urban Population in India (2000-2020)
  • Exhibit 3.2: Net National per Capita Income of India 2011-2015
  • Exhibit 3.3: Top Indian States with highest Urban & Rural IMR per 1000 birth - 2013
  • Exhibit 3.4: Top Ten disease causing death in India (2013-14)
  • Exhibit 4.1: Estimated Market size of the Indian Pharma Manufacturing Industry 2015-2020 USD billion
  • Exhibit 4.2: Estimated CAGR% of the Indian Pharma Manufacturing Industry 2015-2020
  • Exhibit 5.1: Export Value of Pharmaceutical Products from India (in US$ million) from FY 03-04 to FY 13-14
  • Exhibit 5.2: Export Volume of Pharmaceutical Products from India (in thousands Kg) from FY 03-04 to FY 13-14
  • Exhibit 5.3: Top 5 Nations Importing Indian Pharmaceutical Products (in US$ million) in FY 13-14
  • Exhibit 5.4: Import Value of Pharmaceutical Products in India (in US$ million) from FY 03-04 to FY 13-14
  • Exhibit 5.5: Import Volume of Pharmaceutical Products in India (in thousands Kg) from FY 03-04 to FY 13-14
  • Exhibit 5.6: Top 5 Nations Exporting Pharmaceutical Products to India (in US$ million) in FY 13-14
  • Exhibit 6.1: Sector-wise Pharmaceuticals Sales 2011-2016 (est) in US$ million
  • Exhibit 6.2: Growth Drivers and Inhibitors for Pharmaceuticals Manufacturing Industry in India
  • Exhibit 7.1: Code for Marketing practices in Indian Pharmaceuticals Industry
  • Exhibit 9.1.1: Key Information of IDMA
  • Exhibit 9.1.2: Contact details of IDMA
  • Exhibit 9.2.1: Key information of IPMMA
  • Exhibit 9.2.2: Contact details of IPMMA
  • Exhibit 9.3.1: Key Information of IPA
  • Exhibit 9.3.2: Contact details of IPA
  • Exhibit 9.4.1: Key information of OPPI
  • Exhibit 9.4.2: Contact details of OPPI
  • Exhibit 11.1.1: Key Information of Abbott India
  • Exhibit 11.1.2: Contact Information of Abbott India
  • Exhibit 11.1.3: Abbott India in Pharma Manufacturing Value chain
  • Exhibit 11.1.4: Abbott India Consolidated Revenue 2009-2014 (in INR billion)
  • Exhibit 11.1.5: Abbott India Growth Rate 2009-2014 (in %)
  • Exhibit 11.1.6: Estimated Year wise Abbott India Revenue 2015-2020 (in INR billion)
  • Exhibit 11.1.7: Estimated Year-wise Abbott India Revenue Growth 2015-2020 (in %)
  • Exhibit 11.1.8: Top performing brands of Abbott India 2014
  • Exhibit 11.1.9: Product Range of Abbott India
  • Exhibit 11.1.10: SWOT Analysis of Abbott India
  • Exhibit 11.2.1: Key Information of Biocon Limited
  • Exhibit 11.2.2: Contact Information of Biocon Limited
  • Exhibit 11.2.3: Biocon Ltd in Pharma Manufacturing Value Chain
  • Exhibit 11.2.4: Biocon Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.2.5: Year-wise Biocon Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.2.6: Category Wise Revenue Breakup for Biocon Limited 2010-14 (in INR billion)
  • Exhibit 11.2.7: Estimated Year wise Biocon Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.2.8: Estimated Year-wise Biocon Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.2.9: Estimated Category Wise Revenue Breakup for Biocon Limited 2015-20 (in INR billion)
  • Exhibit 11.2.10: Key Products of Biocon Limited
  • Exhibit 11.2.11: Key Services Offered by Biocon Limited
  • Exhibit 11.2.12: SWOT Analysis of Biocon Limited
  • Exhibit 11.3.1: Key Information of Cipla Limited
  • Exhibit 11.3.2: Contact Information of Cipla Limited
  • Exhibit 11.3.3: Cipla Limited in Pharmaceutical Manufacturing Value chain
  • Exhibit 11.3.4: Cipla Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.3.5: Year-wise Cipla Limited Revenue Growth 2010-2014 (in %)
  • Exhibit 11.3.6: Cipla Limited Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.3.7: Year-wise Cipla Limited Export Revenue Growth 2010-2014 (in %)
  • Exhibit 11.3.8: Cipla Limited Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.3.9: Year-wise Cipla Limited Domestic Revenue Growth 2010-2014 (in %)
  • Exhibit 11.3.10: Cipla Limited Product Sales Revenue 2010-2014 (in INR billion)
  • Exhibit 11.3.11: Year-wise Cipla Limited Product Sales Revenue Growth 2010-2014 (in %)
  • Exhibit 11.3.12: Estimated Year wise Cipla Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.3.13: Estimated Year-wise Cipla Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.3.14: Estimated Cipla Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.3.15: Estimated Year-wise Cipla Limited Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.3.16: Estimated Cipla Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.3.17: Estimated Year-wise Cipla Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.3.18: Estimated Cipla Limited Product Sales Revenue 2015-2020 (in INR billion)
  • Exhibit 11.3.19: Estimated Year-wise Cipla Limited Product Sales Revenue Growth 2015-2020 (in %)
  • Exhibit 11.3.20: Key Products of Cipla Limited
  • Exhibit 11.3.21: Key Services of Cipla Limited
  • Exhibit 11.3.22: SWOT Analysis of Cipla Limited
  • Exhibit 11.4.1: Key Information of Dr. Reddy's Laboratories
  • Exhibit 11.4.2: Contact Information of Dr. Reddy's Laboratories
  • Exhibit 11.4.3: Dr. Reddy's Laboratories in Pharmaceuticals Manufacturing Value Chain
  • Exhibit 11.4.4: Dr. Reddy's Laboratories Revenue 2010-2014 (in INR billion)
  • Exhibit 11.4.5: Year-wise Dr. Reddy's Laboratories Revenue Growth 2010-14 (in %)
  • Exhibit 11.4.6: Dr. Reddy's Laboratories Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.4.7: Year-wise Dr. Reddy's Laboratories Domestic Revenue Growth 2010-2014 (in %)
  • Exhibit 11.4.8: Dr. Reddy's Laboratories Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.4.9: Year-wise Dr. Reddy's Laboratories Export Revenue Growth 2010-2014 (in %)
  • Exhibit 11.4.10: Estimated Year wise Dr. Reddy's Laboratories Revenue 2015-2020 (in INR billion)
  • Exhibit 11.4.11: Estimated Year-wise Dr. Reddy's Laboratories Revenue Growth 2015-2020 (in %)
  • Exhibit 11.4.12: Estimated Dr. Reddy's Laboratories Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.4.13: Estimated Year-wise Dr. Reddy's Laboratories Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.4.14: Estimated Dr. Reddy's Laboratories Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.4.15: Estimated Year-wise Dr. Reddy's Laboratories Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.4.16: Key Products of Dr. Reddy's Laboratories
  • Exhibit 11.4.17: Key Services of Dr. Reddy's Laboratories
  • Exhibit 11.4.18: SWOT Analysis of Dr. Reddy's Laboratories
  • Exhibit 11.5.1: Key Information of Sun Pharmaceuticals Limited
  • Exhibit 11.5.2: Contact Information of Sun Pharmaceuticals Limited
  • Exhibit 11.5.3: Sun Pharmaceuticals Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.5.4: Sun Pharmaceuticals Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.5.5: Year-wise Sun Pharmaceuticals Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.5.6: Sun Pharmaceuticals Limited Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.5.7: Year-wise Sun Pharmaceuticals Limited Domestic Revenue Growth 2011-2014 (in %)
  • Exhibit 11.5.8: Sun Pharmaceuticals Limited Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.5.9: Year-wise Sun Pharmaceuticals Limited Export Revenue Growth 2011-2014 (in %)
  • Exhibit 11.5.10: Estimated Year wise Sun Pharmaceuticals Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.5.11: Estimated Year-wise Sun Pharmaceuticals Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.5.12: Estimated Sun Pharmaceuticals Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.5.13: Estimated Year-wise Sun Pharmaceuticals Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.5.14: Estimated Sun Pharmaceuticals Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.5.15: Estimated Year-wise Sun Pharmaceuticals Limited Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.5.16: Key Products of Sun Pharmaceuticals Limited
  • Exhibit 11.5.17: SWOT Analysis of Sun Pharmaceuticals Limited
  • Exhibit 11.6.1: Key Information of Lupin Limited
  • Exhibit 11.6.2: Contact Information of Lupin Limited
  • Exhibit 11.6.3: Lupin Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.6.4: Lupin Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.6.5: Year-wise Lupin Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.6.6: Lupin Limited Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.6.7: Year-wise Lupin Limited Domestic Revenue Growth 2010-2014 (in %)
  • Exhibit 11.6.8: Lupin Limited Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.6.9: Year-wise Lupin Limited Export Revenue Growth 2010-2014 (in %)
  • Exhibit 11.6.10: Estimated Year wise Lupin Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.6.11: Estimated Year-wise Lupin Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.6.12: Estimated Lupin Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.6.13: Estimated Year-wise Lupin Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.6.14: Estimated Lupin Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.6.15: Estimated Year-wise Lupin Limited Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.6.17: Key Products of Lupin Limited
  • Exhibit 11.6.17: SWOT Analysis of Lupin Limited
  • Exhibit 11.7.1: Key Information of Aurobindo Pharma Limited
  • Exhibit 11.7.2: Contact Information of Aurobindo Pharma Limited
  • Exhibit 11.7.3: Aurobindo Pharma Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.7.4: Aurobindo Pharma Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.7.5: Year-wise Aurobindo Pharma Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.7.6: Estimated Year wise Aurobindo Pharma Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.7.7: Estimated Year-wise Aurobindo Pharma Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.7.8: SWOT Analysis of Aurobindo Pharmaceuticals
  • Exhibit 11.8.1: Key Information of Torrent Pharmaceuticals Limited
  • Exhibit 11.8.2: Contact Information of Torrent Pharmaceuticals Limited
  • Exhibit 11.8.3: Torrent Pharmaceuticals Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.8.4: Torrent Pharmaceuticals Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.8.5: Year-wise Torrent Pharmaceuticals Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.8.6: Estimated Year wise Torrent Pharmaceuticals Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.8.7: Estimated Year-wise Torrent Pharmaceuticals Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.8.8: Key Products of Torrent Pharmaceuticals Limited
  • Exhibit 11.8.9: SWOT Analysis of Torrent Pharmaceuticals Limited
  • Exhibit 11.9.1: Key Information of Divis Laboratories Limited
  • Exhibit 11.9.2: Contact Information of Divis Laboratories Limited
  • Exhibit 11.9.3: Divis Laboratories Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.9.4: Divis Laboratories Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.9.5: Year-wise Divis Laboratories Limited Revenue Growth 2010-14 (in %)
  • Exhibit 11.9.6: Divis Laboratories Limited Domestic Revenue 2010-2014 (in INR billion)
  • Exhibit 11.9.7: Year-wise Divis Laboratories Limited Domestic Revenue Growth 2010-2014 (in %)
  • Exhibit 11.9.8: Divis Laboratories Limited Export Revenue 2010-2014 (in INR billion)
  • Exhibit 11.9.9: Year-wise Divis Laboratories Limited Export Revenue Growth 2010-2014 (in %)
  • Exhibit 11.9.10: Estimated Year wise Divis Laboratories Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.9.11: Estimated Year-wise Divis Laboratories Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.9.12: Estimated Divis Laboratories Limited Domestic Revenue 2015-2020 (in INR billion)
  • Exhibit 11.9.13: Estimated Year-wise Divis Laboratories Limited Domestic Revenue Growth 2015-2020 (in %)
  • Exhibit 11.9.14: Estimated Divis Laboratories Limited Export Revenue 2015-2020 (in INR billion)
  • Exhibit 11.9.15: Estimated Year-wise Divis Laboratories Limited Export Revenue Growth 2015-2020 (in %)
  • Exhibit 11.9.16: Key Products of Divis Laboratories Limited
  • Exhibit 11.9.17: SWOT Analysis of Divis Laboratories Limited
  • Exhibit 11.10.1: Key Information of Ipca Laboratories Limited
  • Exhibit 11.10.2: Contact details of Ipca Laboratories Limited
  • Exhibit 11.10.3: IPCA Laboratories Limited in Pharma Manufacturing Value Chain
  • Exhibit 11.10.4: IPCA Laboratories Limited Revenue 2010-2014 (in INR billion)
  • Exhibit 11.10.5: Year-wise IPCA Laboratories Limited Revenue Growth 2010-2014 (in %)
  • Exhibit 11.10.6: Estimated Year wise IPCA Laboratories Limited Revenue 2015-2020 (in INR billion)
  • Exhibit 11.10.7: Estimated Year-wise IPCA Laboratories Limited Revenue Growth 2015-2020 (in %)
  • Exhibit 11.10.8: IPCA Laboratories Limited Revenue by Geography 2014 (in INR billion)
  • Exhibit 11.1.10.9: Export and domestic revenue of IPCA Laboratories Limited
  • Exhibit 11.10.10: IPCA Laboratories Limited Sales Break-up 2014 (in INR billion)
  • Exhibit 11.10.11: Key Products of IPCA Laboratories Limited
  • Exhibit 11.10.12: Key Services of IPCA Laboratories Limited
  • Exhibit 11.10.13: SWOT Analysis of IPCA Laboratories Limited
  • Exhibit 11.10.14: Key Customers of IPCA Laboratories Limited
  • Exhibit 12.1: Revenues of few Key Pharma Companies
  • Exhibit 12.2: Top Pharmaceutical Company by Net Sales
  • Exhibit 13.1: PESTEL Analysis of the Indian Pharma Industry
  • Exhibit 13.2: SWOT Analysis of Indian Pharmaceuticals Manufacturing Industry
  • Exhibit 13.3: Porter's Five Forces Analysis of Indian Pharmaceuticals Manufacturing Industry
Back to Top